antipsychotic drugs market, antipsychotic drugs market size, antipsychotic drugs market share, antipsychotic drugs market trends, antipsychotic drugs global market, antipsychotic drugs market forecast
How much is the antipsychotic drugs market worth, and how is it expected to expand?
The antipsychotic drugs market size has grown rapidly in recent years. It will grow from $19.5 billion in 2024 to $21.45 billion in 2025 at a compound annual growth rate (CAGR) of 10.0%. The growth in the historic period can be attributed to the rising prevalence of mental health disorders, development of second-generation antipsychotics, growing geriatric population, improvements in healthcare infrastructure, and high investment in research and development.
The antipsychotic drugs market size is expected to see strong growth in the next few years. It will grow to $31.04 billion in 2029 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to the increasing incidence of schizophrenia and bipolar disorder, supportive government policies and funding, rising demand for personalized medicine, focus on reducing side effects, and growing mental health advocacy and support groups. Major trends in the forecast period include integration of digital health tools for monitoring, development of novel mechanisms of action, increasing focus on combination therapies, adoption of pharmacogenomics for tailored treatments, emphasis on patient-centric drug development.
Get Your Free Sample of The Global Antipsychotic Drugs Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18780&type=smp
Which industry factors have accelerated the antipsychotic drugs market’s expansion?
The growing incidence of mental disorders is expected to propel the growth of the antipsychotic drug market going forward. Mental disorders, often known as mental illnesses, are ailments that impact a person’s thinking, behavior, mood, and mental health. The mental disorder cases can be affected by stress levels, societal pressures, genetic predisposition, biochemical imbalance, neurodevelopmental issues, and physical health conditions. Antipsychotic drugs control mental disorders by altering the activity of neurotransmitters, primarily dopamine and serotonin, to reduce psychotic symptoms, stabilize mood, and improve cognitive and emotional function. For instance, in November 2023, according to a survey conducted by the Substance Abuse and Mental Health Services Administration (SAMHSA), a US-based government agency for public health, approximately 6% of adults aged 18 or older, equivalent to 15.4 million individuals, reported experiencing serious mental illness (SMI). Furthermore, in September 2024, according to the Australian Institute of Health and Welfare, an Australia-based government agency, the number of individuals living with dementia in Australia is expected to more than double from around 411,100 in 2023 to 849,300 by 2058. This increase will affect approximately 315,500 men and 533,800 women. Therefore, a growing incidence of mental disorders is driving the antipsychotic drug market.
What are the primary segments of the antipsychotic drugs market?
The antipsychotic drugs market covered in this report is segmented –
1) By Therapeutic Class: First Generation, Second Generation, Third Generation
2) By Disease: Schizophrenia, Bipolar Disorder, Unipolar Depression, Dementia, Other Diseases
3) By Distribution Channel: Hospital Pharmacies, Drug Stores, Online Pharmacies
Subsegments:
1) By First Generation: Typical Antipsychotics, Phenothiazines, Butyrophenones, Thioxanthenes, Dibenzoxazepines
2) By Second Generation: Atypical Antipsychotics, Clozapine, Olanzapine, Risperidone, Quetiapine, Aripiprazole, Paliperidone, Lurasidone
3) By Third Generation: Partial Dopamine Agonists, Aripiprazole, Brexpiprazole, Cariprazine
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/antipsychotic-drugs-global-market-report
Which firms are leading the antipsychotic drugs market?
Major companies operating in the antipsychotic drugs market are Pfizer Inc., Johnson & Johnson Services Inc., Merck And Co. Inc., AbbVie Inc., Bristol-Myers Squibb Company, AstraZeneca PLC, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lilly And Company, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co. Ltd., Aurobindo Pharma Ltd., Cipla Ltd., H. Lundbeck A/S, Dr. Reddy’s Laboratories Ltd., Intas Pharmaceuticals Ltd., Apotex Inc., Lupin Limited, Glenmark Pharmaceuticals Ltd., Torrent Pharmaceuticals Ltd., Alkermes plc
Which market trends are set to define the future of the antipsychotic drugs market?
Major companies operating in the antipsychotic drug market are focused on developing advanced medical products, such as subcutaneous atypical antipsychotic injections, to offer improved patient compliance and enhanced efficacy compared to traditional oral medications. Subcutaneous atypical antipsychotic injections are psychiatric drugs that are given under the skin to treat mental illnesses, maintain stable blood levels, and improve symptom control. For instance, in April 2023, Teva Pharmaceutical Industries Ltd., an Israel-based pharmaceutical company, and MedinCell SA, a France-based manufacturer of biological products and pharmaceutical preparations, launched U.S. Food and Drug Administration (FDA)-approved UZEDY. It is an extended-release injectable formulation of risperidone designed as a long-acting subcutaneous injection that offers flexible dosing intervals of one or two months. UZEDY utilizes MedinCell’s proprietary SteadyTeq technology, which ensures a steady release of the medication, reaching therapeutic levels within 6–24 hours of administration. In clinical trials, UZEDY demonstrated up to an 80% reduction in the risk of schizophrenia relapse compared to placebo. It is intended to address adherence issues commonly associated with oral antipsychotics, which often lead to relapse.
Which geographic trends are shaping the antipsychotic drugs market, and which region has the highest market share?
North America was the largest region in the antipsychotic drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antipsychotic drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Antipsychotic Drugs Market Report 2025 Offer?
The antipsychotic drugs market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Antipsychotic drugs are a class of medications used primarily to manage and treat symptoms of psychosis, which can include delusions, hallucinations, paranoia, and disordered thinking. Psychosis is commonly associated with psychiatric conditions such as schizophrenia, bipolar disorder, and severe depression. These medications are also sometimes referred to as neuroleptics or major tranquilizers.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18780
About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
